Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Prostate Cancer treatment details. Biologic therapy. University of Chicago, Chicago, Illinois, United States

Survival: 15.3 months
Toxicity Grade: 4
Treatments: Biologic therapy
Country: United States
City/State/Province: Chicago, Illinois
Hospital: University of Chicago
Journal: Link
Date: 1/2004

Patients: This Phase II trial involved 58 patients with hormone refractory prostate cancer. Median age was 72 years. All patients had received previous hormone therapy, 38 patients had received prior radiotherapy, and 42 patients had received prior surgery.

Treatment: The treatment consisted of Suramin (a drug typically used against trypanosomiasis sleeping sickness).

Toxicity: Grade 3 or 4 toxicities included edema, elevated alkaline phosphatase, hematologic, bilirubin, pain, fatigue, anorexia, diarrhea, and respiratory.

Results: Median survival was 15.3 months.

Correspondence: Nicholas J. Vogelzang, MD

E-mail to a Friend Email Physician More Information